
Canada’s decision to suspend the use of the AstraZeneca-Oxford vaccine in Canadians under 55 during a surging third wave and a slow vaccination rollout is a calculated risk.
More...
From
http://start.westnet.ca News
News Provided By
WestNet Wireless Internet